Method of treatment for mucocutaneous herpes simplex infections
US4225614A · kind A · utility
8Cited by
0References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 14, 1978 |
| Grant date | Sep 30, 1980 |
| Priority date | — |
| Expiry date | Dec 14, 1998 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating mucocutaneous herpes simplex infections in man or other animals susceptible to said infections comprising the administration of an amount of zinc in the form of a salt or a hydroxycarboxylic acid or aminocarboxylic acid complex thereof, therapeutically effective in the treatment of said infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.